Abstract
In the present review, the basis of non invasive assessment of CAD, the most recent technical developments and results obtained by PET in cardiovascular research and clinical cardiology are described. PET has provided a wealth of new information in the field of cardiac pathophysiology and remains the gold standard for non-invasive measurements of MBF and CFR against which new techniques should be tested. The possibility to combine this relevant functional information with the anatomic details on luminal and arterial wall abnormalities, provided by multislice CT with or without the use of “hybrid” scanners, offers new opportunities for comprehensive non-invasive assessment of CAD and efficacy of new treatments.
Keywords: Positron emission tomography, myocardial perfusion, coronary artery disease
Current Pharmaceutical Design
Title: Radionuclide PET and PET/CT in Coronary Artery Disease
Volume: 14 Issue: 18
Author(s): D. Neglia, O. Rimoldi, P. A. Kaufmann and P. G. Camici
Affiliation:
Keywords: Positron emission tomography, myocardial perfusion, coronary artery disease
Abstract: In the present review, the basis of non invasive assessment of CAD, the most recent technical developments and results obtained by PET in cardiovascular research and clinical cardiology are described. PET has provided a wealth of new information in the field of cardiac pathophysiology and remains the gold standard for non-invasive measurements of MBF and CFR against which new techniques should be tested. The possibility to combine this relevant functional information with the anatomic details on luminal and arterial wall abnormalities, provided by multislice CT with or without the use of “hybrid” scanners, offers new opportunities for comprehensive non-invasive assessment of CAD and efficacy of new treatments.
Export Options
About this article
Cite this article as:
Neglia D., Rimoldi O., Kaufmann A. P. and Camici G. P., Radionuclide PET and PET/CT in Coronary Artery Disease, Current Pharmaceutical Design 2008; 14 (18) . https://dx.doi.org/10.2174/138161208784746662
DOI https://dx.doi.org/10.2174/138161208784746662 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Strategies for the Management of Acute Decompensated Heart Failure
Current Cardiology Reviews Radioligands for the Angiotensin II Subtype 1 (AT1) Receptor
Current Topics in Medicinal Chemistry New Approaches for the Treatment of Chagas Disease
Current Drug Targets Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Current Medicinal Chemistry Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Obesity and Pregnancy
Current Women`s Health Reviews Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment
Current Pharmaceutical Biotechnology Diabetic Cardiomyopathy: Electromechanical Cellular Alterations
Current Vascular Pharmacology Performance Improvement of Gene Selection Methods using Outlier Modification Rule
Current Bioinformatics Recent Patents on Cardiovascular Stem Cells
Recent Patents on Cardiovascular Drug Discovery High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design Infective Endocarditis Complicating Hypertrophic Obstructive Cardiomyopathy: Is Antibiotic Prophylaxis Really Unnecessary?
Current Cardiology Reviews Hypoxia and Fetal Heart Development
Current Molecular Medicine Gene Replacement Therapies for Duchenne Muscular Dystrophy Using Adeno-Associated Viral Vectors
Current Gene Therapy Editorial[Hot Topic:Stem Cell Therapy for Cardiovascular Diseases:Are We Still at the Beginning of A Long Road?(Guest Editor:Lino M Goncalves)
Cardiovascular & Hematological Disorders-Drug Targets Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry